Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier

Zheyu Shen, Wei Wei, Yongjiang Zhao, Guanghui Ma, Toshiaki Dobashi, Yasuyuki Maki, Zhiguo Su, Jinpei Wan

研究成果: ジャーナルへの寄稿記事

69 引用 (Scopus)

抄録

Thermosensitive Poly(N-isopropylacrylamide-co-acrylamide-co-allylamine) (PNIPAM-AAm-AA)-conjugated albumin nanospheres (PAN) was developed as a new thermal targeting anti-cancer drug carrier by conjugating PNIPAM-AAm-AA on the surface of albumin nanospheres (AN). AN with diameter below 200 nm and narrow size distribution was successfully prepared in the first step with desolvation technique. PNIPAM-AAm-AA with different molecular weight (Mw) was synthesized in the second step by radical polymerization and conjugated onto the surface of AN. Anti-cancer drug adriamycin (ADR) was then entrapped into the AN and PAN during the particle preparation. Compared with AN, the release rate of ADR from PAN in trypsin solution was slower, and decreased with increasing the conjugation amounts (hairy density) or Mw of PNIPAM-AAm-AA (hairy length). Moreover, the release of ADR from PAN above the cloud-point temperature (Tcp) of PNIPAM-AAm-AA became faster due to shrinkage of hairy thermosensitive polymer. To testify the thermal targetability in vivo, PAN was incubated with HepG2 cells. As expected, PAN can target cancer cells above the Tcp of PNIPAM-AAm-AA, whereas it cannot below the Tcp. These results might reflect that PAN may selectively accumulate onto solid tumors that are maintained above physiological temperature due to local hyperthermia.

元の言語英語
ページ(範囲)271-282
ページ数12
ジャーナルEuropean Journal of Pharmaceutical Sciences
35
発行部数4
DOI
出版物ステータス出版済み - 11 15 2008
外部発表Yes

Fingerprint

Nanospheres
Drug Carriers
Albumins
Polymers
Hot Temperature
Doxorubicin
Neoplasms
Molecular Weight
Induced Hyperthermia
Temperature
Hep G2 Cells
Polymerization
Trypsin
poly(N-isopropylacrylamide-co-acrylamide-co-allylamine)
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

これを引用

Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier. / Shen, Zheyu; Wei, Wei; Zhao, Yongjiang; Ma, Guanghui; Dobashi, Toshiaki; Maki, Yasuyuki; Su, Zhiguo; Wan, Jinpei.

:: European Journal of Pharmaceutical Sciences, 巻 35, 番号 4, 15.11.2008, p. 271-282.

研究成果: ジャーナルへの寄稿記事

Shen, Zheyu ; Wei, Wei ; Zhao, Yongjiang ; Ma, Guanghui ; Dobashi, Toshiaki ; Maki, Yasuyuki ; Su, Zhiguo ; Wan, Jinpei. / Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier. :: European Journal of Pharmaceutical Sciences. 2008 ; 巻 35, 番号 4. pp. 271-282.
@article{4217263bab1644bda45098f4b72cbbf2,
title = "Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier",
abstract = "Thermosensitive Poly(N-isopropylacrylamide-co-acrylamide-co-allylamine) (PNIPAM-AAm-AA)-conjugated albumin nanospheres (PAN) was developed as a new thermal targeting anti-cancer drug carrier by conjugating PNIPAM-AAm-AA on the surface of albumin nanospheres (AN). AN with diameter below 200 nm and narrow size distribution was successfully prepared in the first step with desolvation technique. PNIPAM-AAm-AA with different molecular weight (Mw) was synthesized in the second step by radical polymerization and conjugated onto the surface of AN. Anti-cancer drug adriamycin (ADR) was then entrapped into the AN and PAN during the particle preparation. Compared with AN, the release rate of ADR from PAN in trypsin solution was slower, and decreased with increasing the conjugation amounts (hairy density) or Mw of PNIPAM-AAm-AA (hairy length). Moreover, the release of ADR from PAN above the cloud-point temperature (Tcp) of PNIPAM-AAm-AA became faster due to shrinkage of hairy thermosensitive polymer. To testify the thermal targetability in vivo, PAN was incubated with HepG2 cells. As expected, PAN can target cancer cells above the Tcp of PNIPAM-AAm-AA, whereas it cannot below the Tcp. These results might reflect that PAN may selectively accumulate onto solid tumors that are maintained above physiological temperature due to local hyperthermia.",
author = "Zheyu Shen and Wei Wei and Yongjiang Zhao and Guanghui Ma and Toshiaki Dobashi and Yasuyuki Maki and Zhiguo Su and Jinpei Wan",
year = "2008",
month = "11",
day = "15",
doi = "10.1016/j.ejps.2008.07.006",
language = "English",
volume = "35",
pages = "271--282",
journal = "European Journal of Pharmaceutical Sciences",
issn = "0928-0987",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier

AU - Shen, Zheyu

AU - Wei, Wei

AU - Zhao, Yongjiang

AU - Ma, Guanghui

AU - Dobashi, Toshiaki

AU - Maki, Yasuyuki

AU - Su, Zhiguo

AU - Wan, Jinpei

PY - 2008/11/15

Y1 - 2008/11/15

N2 - Thermosensitive Poly(N-isopropylacrylamide-co-acrylamide-co-allylamine) (PNIPAM-AAm-AA)-conjugated albumin nanospheres (PAN) was developed as a new thermal targeting anti-cancer drug carrier by conjugating PNIPAM-AAm-AA on the surface of albumin nanospheres (AN). AN with diameter below 200 nm and narrow size distribution was successfully prepared in the first step with desolvation technique. PNIPAM-AAm-AA with different molecular weight (Mw) was synthesized in the second step by radical polymerization and conjugated onto the surface of AN. Anti-cancer drug adriamycin (ADR) was then entrapped into the AN and PAN during the particle preparation. Compared with AN, the release rate of ADR from PAN in trypsin solution was slower, and decreased with increasing the conjugation amounts (hairy density) or Mw of PNIPAM-AAm-AA (hairy length). Moreover, the release of ADR from PAN above the cloud-point temperature (Tcp) of PNIPAM-AAm-AA became faster due to shrinkage of hairy thermosensitive polymer. To testify the thermal targetability in vivo, PAN was incubated with HepG2 cells. As expected, PAN can target cancer cells above the Tcp of PNIPAM-AAm-AA, whereas it cannot below the Tcp. These results might reflect that PAN may selectively accumulate onto solid tumors that are maintained above physiological temperature due to local hyperthermia.

AB - Thermosensitive Poly(N-isopropylacrylamide-co-acrylamide-co-allylamine) (PNIPAM-AAm-AA)-conjugated albumin nanospheres (PAN) was developed as a new thermal targeting anti-cancer drug carrier by conjugating PNIPAM-AAm-AA on the surface of albumin nanospheres (AN). AN with diameter below 200 nm and narrow size distribution was successfully prepared in the first step with desolvation technique. PNIPAM-AAm-AA with different molecular weight (Mw) was synthesized in the second step by radical polymerization and conjugated onto the surface of AN. Anti-cancer drug adriamycin (ADR) was then entrapped into the AN and PAN during the particle preparation. Compared with AN, the release rate of ADR from PAN in trypsin solution was slower, and decreased with increasing the conjugation amounts (hairy density) or Mw of PNIPAM-AAm-AA (hairy length). Moreover, the release of ADR from PAN above the cloud-point temperature (Tcp) of PNIPAM-AAm-AA became faster due to shrinkage of hairy thermosensitive polymer. To testify the thermal targetability in vivo, PAN was incubated with HepG2 cells. As expected, PAN can target cancer cells above the Tcp of PNIPAM-AAm-AA, whereas it cannot below the Tcp. These results might reflect that PAN may selectively accumulate onto solid tumors that are maintained above physiological temperature due to local hyperthermia.

UR - http://www.scopus.com/inward/record.url?scp=53849116072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53849116072&partnerID=8YFLogxK

U2 - 10.1016/j.ejps.2008.07.006

DO - 10.1016/j.ejps.2008.07.006

M3 - Article

C2 - 18721874

AN - SCOPUS:53849116072

VL - 35

SP - 271

EP - 282

JO - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

SN - 0928-0987

IS - 4

ER -